Catalent Biologics Content

  1. Catalent Capacity Update April 2025: Fill/Finish 4/25/2025

    This presentation highlights how simplified execution with development, filling, and analytics under one roof ensures safe, efficacious products reach patients in need.

  2. Mastering QbD For Successful Process Validation Campaigns And Commercial Manufacturing Of Biologics 2/18/2025

    In this presentation, industry-leading bioprocess experts explore the challenges and opportunities that arise when implementing Quality by Design (QbD) in biologics development and manufacturing.

  3. Formulation Through Manufacturing Under One Roof 2/18/2025

    Partner with a CDMO that understands the unique challenges of emerging biopharma, providing expert guidance in formulation development, manufacturing, and regulatory navigation.

  4. High-Throughput Preformulation Development Platform For Biologics 11/21/2019

    A high-throughput formulation development for sample preparation and sample analysis enabled a simple and less labor-intensive screening of a broad range of conditions in considerably less time.

  5. Strategies To Achieve Successful Approval And Launch 11/18/2019

    Four experts share how scale-up, regulatory expectations, demand forecasting, and process validation all play a role in the success of a biologic when embarking upon the commercial manufacturing journey.

  6. Ensuring Success In Early Biopharmaceutical Formulation Development 6/10/2019

    Biopharmaceuticals tend to be highly unstable. A pilot formulation study at the early drug substance development stage can make things considerably easier at the manufacturing stage.

  7. High-Throughput Formulation Development For High-Concentration mAbs 6/10/2019

    How a high-throughput, microwell plate platform can be used to economically screen a model IgG1 mAb at 120 mg/ml in 96 formulations while minimizing protein consumed and generating large amount of data.

  8. Achieving A Successful Drug Product Technology Transfer

    Get insights on key considerations for a successful process transfer for manufacturing a drug product, including a case study on overcoming challenges in a process transfer for a sterile diluent.

  9. Keys To A Successful Rapid Commercial Launch

    Combining a rapid launch following regulatory approval with effective messaging and post-launch services can provide a competitive advantage.

  10. Reaching First-In-Human Trials Faster: Connect With The Right Partner

    Assessing outsourcing partners’ credentials in people, technology, supply chains, and integration will make all the difference as sponsors aim to streamline processes on the path to commercialization.